Medline Inc. (ETR:L10)
Germany · Delayed Price · Currency is EUR | Market Cap | 27.08B |
| Revenue (ttm) | 26.25B +12.1% |
| Net Income | 614.64M -45.3% |
| EPS | 0.70 +998.4% |
| Shares Out | n/a |
| PE Ratio | 44.06 |
| Forward PE | 15.80 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 30.80 |
| Previous Close | 30.80 |
| Day's Range | 30.80 - 30.80 |
| 52-Week Range | 29.30 - 38.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Medline
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam g... [Read more]
Financial Performance
In 2025, Medline's revenue was $28.43 billion, an increase of 11.47% compared to the previous year's $25.51 billion. Earnings were $1.16 billion, a decrease of -3.42%.
Financial numbers in USD Financial StatementsNews
Medline Earnings Call Transcript: Q2 2026
Q2 2026 saw 12% sales growth and a 13% rise in adjusted EBITDA, driven by strong demand and new customer wins. Guidance for organic sales was raised, but adjusted EBITDA was lowered due to inflation, Tracy fire costs, and operational investments. Margin pressures are being addressed with cost-saving initiatives.
Medline Earnings release: Q2 2026
Medline released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Medline Slides: Q2 2026
Medline has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
Medline Quarterly report: Q2 2026
Medline has published its Q2 2026 quarterly earnings report on August 5, 2026.
Medline Reports Second Quarter and First Six Months 2026 Results
Second quarter net sales of $7.7 billion, an increase of 11.6% Second quarter net income of $139 million, a decrease of 58.3% Second quarter Adjusted EBITDA1 of $1.1 billion, an increase of 13.4% Firs...
Kaplan Fox Notifies Medline Inc. (MDLN) Investors of a Securities Investigation into the Company
New York, New York--(Newsfile Corp. - July 29, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CL...
Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
Cutting-edge distribution center to reinforce Medline's supply chain resilience in California NORTHFIELD, Ill., July 20, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has announced plans to open a new d...
Kaplan Fox Announces a Securities Investigation into Medline Inc. (MDLN) - Investors Encouraged to Contact the Firm
New York, New York--(Newsfile Corp. - July 20, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CL...
Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
Massive new medical supplies distribution space represents 45% expansion of Medline's customer-facing NorCal footprint NORTHFIELD, Ill., July 6, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has announc...
Medline to report second quarter 2026 results on August 5, 2026
NORTHFIELD, Ill., July 01, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report second quarter 2026 financial results on Wednesday, August 5, 2026.
Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters
BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (“AVI”), a medical device company specializing in developing advanced vascular access solutions, and Medline, the largest provider of medical-s...
Medline Transcript: AGM 2026
The meeting highlighted strong 2025 performance, with $2.4 billion in new customer signings and ongoing investments in technology and product innovation. All board nominees and proposals, including executive compensation and auditor ratification, were approved.
Medline Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026
Management emphasized proactive quality controls, voluntary recalls, and minimal financial impact from recent plant shutdowns. Strong Q1 growth led to raised full-year guidance, with continued investments in automation, brand penetration, and M&A. Margin improvement and long-term earnings growth are expected, supported by operational leverage and strategic capital allocation.
Medline Transcript: 46th Annual William Blair Growth Stock Conference
The company leverages a vertically integrated model and extensive distribution network to drive growth through prime vendor contracts and customer-focused product innovation. Despite recent FDA warning letters and inflationary pressures, guidance for 2026 remains strong, with continued investment in quality and supply chain resiliency.
Medline draws another US FDA warning in two months over quality lapses
The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the second such action against the company in two months.
Medline's Prime Vendor model expands outside the United States
Agreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S. NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced that Medline C...
Medline Inc. announces closing of upsized secondary offering of Class A common stock
NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Clas...
Medline announces participation in upcoming investor conferences
NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that members of the executive leadership team will be participating in the following investor...
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
EscharEx ® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue ...
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
NORTHFIELD, Ill., May 21, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A ...
Medline expands animal health portfolio with spay/neuter surgical packs
Ready-to-use packs help reduce prep time and improve inventory management, allowing organizations to focus more on patient care NORTHFIELD, Ill., May 20, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) an...
Medline Registration statement: Registration filing
Medline filed a registration statement on May 20, 2026, providing details about a securities offering with the SEC.
Medline Inc. announces launch of secondary offering of Class A common stock
NORTHFIELD, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and...
Medline deploys new AutoStore installation at distribution center in Aurora, Colorado
NORTHFIELD Ill., May 18, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has unveiled a new AutoStore™ installation at its distribution center in Aurora, Colo.
Medline Earnings Call Transcript: Q1 2026
Q1 2026 saw 11% sales growth, driven by strong Supply Chain Solutions and new customer wins, but adjusted EBITDA fell 11% due to higher costs and tariffs. Full-year organic sales guidance was raised to 8.5%-9.5%, while EBITDA guidance remains unchanged, balancing tariff relief with operational investments and inflationary headwinds.